| PERIOD ENDING | 30-Sep-09 | 27-Jun-09 | 28-Mar-09 | 27-Dec-08 | | Total Revenue | 197,354 | 189,875 | 193,047 | 181,276 | | Cost of Revenue | 88,958 | 82,024 | 84,236 | 76,988 | | | Gross Profit | 108,396 | 107,851 | 108,811 | 104,288 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 22,081 | 19,349 | 20,412 | 18,176 | | Non Recurring |
-
|
-
|
-
|
-
| | Others | 3,774 | 3,305 | 3,625 | 3,224 | | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | 82,541 | 85,197 | 84,774 | 82,888 | | | Income from Continuing Operations | | Total Other Income/Expenses Net |
-
|
-
|
-
|
-
| | Earnings Before Interest And Taxes | (1,857) | 85,197 | 84,774 | 82,888 | | Interest Expense | (64,848) | 21,226 | 21,640 | 21,982 | | Income Before Tax | 62,991 | 63,971 | 63,134 | 60,906 | | Income Tax Expense | 21,380 | 22,583 | 22,830 | 21,307 | | Minority Interest |
-
|
-
|
-
|
-
| | | | Net Income From Continuing Ops | 41,611 | 41,388 | 40,304 | 39,599 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 41,611 | 41,388 | 40,304 | 39,599 | | Preferred Stock And Other Adjustments |
-
|
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $41,611 | $41,388 | $40,304 | $39,599 |
|
0.31% Nasdaq 0.00%
Income Statement
